hotspot -WSS

hotspot

author：comprehensive 2025-09-30 22:10:17 - browse：5

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Rep. Raul Ruiz on the physician shortage and more

WSS

How to protect coverage of PrEP

How to pay for weight loss drugs and save Medicare

How to protect coverage of PrEP

How to pay for weight loss drugs and save Medicare

Doctors have an ethical obligation to be advocates

Will the market for weight loss drugs really reach $100 billion?

hotspot

hotspot

focus

Novavax promises a turnaround & Lilly roils the obesity market

Diagnostic tests are hitting their mathematical limits

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What Henrietta Lacks's story taught me about my role as a doctor

Medical records are filled with copy

Despite FDA concern, risk that CAR

State Dept. review finds Biden bears some blame for Afghanistan failures

Despite FDA concern, risk that CAR

Wildfire smoke exposes gaps in outdoor worker protections

Thousands protest mob assault of women who were paraded naked in remote Indian border state

focus

Takeda, Janssen join wearable maker to measure scratching

Statins reduce cardiovascular risk in people living with HIV

Fetal surgery at risk from Dobbs and new abortion restrictions

Clinic falsely told dozens they had Alzheimer's, suits say

Pediatric cancer treatments threatened by a new FDA policy

As biotech industry slumps, bioscience job market is upside down

knowledge

hotspot

Wikipedia

explore